Prostacyclin effect on cardiovascular system in man evaluated by echocardiography

Prostaglandins Med. 1981 Dec;7(6):501-10. doi: 10.1016/0161-4630(81)90040-9.

Abstract

This was an echocardiographic study of the cardiovascular effects of prostacyclin (PGI2) infused intravenously to human volunteers at the rate of 20 ng . kg-1 . min-1 for 10 minutes. The following parameters were recorded in the steady state, at one-minute intervals throughout infusion and the ensuing recovery period: systolic, diastolic, and mean blood pressure (SBP, DBP, MBP); heart rate (HR); left ventricle end-diastolic (EDD) and end-systolic diameter (ESD); stroke volume index (SVI); cardiac index (CI); peripheral vascular resistance (PVR); left ventricle fractional shortening (FS) and ejection fraction (EF). We detected a progressive reduction of MBP without any HR modification. MBP reduction was associated with a reduction of PVR and a parallel rise of CI and SVI. There was also an increase of FS and EF reflecting a reduced ESD. We conclude that PGI2 infused in man at the rate stated above causes hypotension reflecting an arterial vasodilating effect; a lack of heart rate reflex response to afterload reduction (probably a nerve-mediated effect of PGI2); and no venous vasodilation, judging from the absence of any change in end-diastolic diameter.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Blood Pressure / drug effects
  • Cardiovascular System / drug effects*
  • Echocardiography
  • Epoprostenol / pharmacology*
  • Female
  • Heart Rate / drug effects
  • Humans
  • Male
  • Myocardial Contraction / drug effects
  • Prostaglandins / pharmacology*
  • Stroke Volume / drug effects
  • Vascular Resistance / drug effects
  • Vasodilation / drug effects

Substances

  • Prostaglandins
  • Epoprostenol